enVVeno Medical Corporation (NASDAQ:NVNO – Get Free Report) was the recipient of a significant drop in short interest in the month of June. As of June 15th, there was short interest totaling 14,788 shares, a drop of 78.9% from the May 31st total of 70,022 shares. Based on an average daily volume of 7,743 shares, the short-interest ratio is presently 1.9 days. Approximately 2.6% of the shares of the stock are sold short.
enVVeno Medical Stock Performance
NASDAQ:NVNO traded down $0.21 during mid-day trading on Friday, hitting $10.84. 9,898 shares of the company’s stock traded hands, compared to its average volume of 7,593. The firm’s 50 day simple moving average is $10.77 and its 200 day simple moving average is $10.98. The company has a market cap of $7.26 million, a PE ratio of -0.42 and a beta of 1.10. enVVeno Medical has a 1 year low of $8.67 and a 1 year high of $196.70.
enVVeno Medical (NASDAQ:NVNO – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported ($5.89) earnings per share for the quarter, beating the consensus estimate of ($8.40) by $2.51.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on enVVeno Medical
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. ACT Capital Management LLC acquired a new position in shares of enVVeno Medical during the 4th quarter valued at $37,000. Jane Street Group LLC grew its stake in shares of enVVeno Medical by 149.2% in the fourth quarter. Jane Street Group LLC now owns 178,855 shares of the company’s stock valued at $57,000 after buying an additional 107,084 shares in the last quarter. CM Management LLC grew its stake in shares of enVVeno Medical by 108.3% in the fourth quarter. CM Management LLC now owns 1,250,000 shares of the company’s stock valued at $401,000 after buying an additional 650,000 shares in the last quarter. Kingdon Capital Management L.L.C. raised its holdings in shares of enVVeno Medical by 58.2% during the 3rd quarter. Kingdon Capital Management L.L.C. now owns 1,359,261 shares of the company’s stock valued at $1,232,000 after buying an additional 500,000 shares during the period. Finally, Perceptive Advisors LLC purchased a new position in enVVeno Medical in the 2nd quarter worth approximately $5,127,000. 34.71% of the stock is owned by hedge funds and other institutional investors.
enVVeno Medical Company Profile
enVVeno Medical, Inc is a clinical‐stage medical device company focused on the development and commercialization of subcutaneous vascular access systems for patients requiring repeated or long‐term intravenous therapy. Through its proprietary Freedom® platform, the company aims to offer an implantable alternative to traditional peripherally inserted central catheters (PICCs) and external tunneled catheters, addressing complications such as infection risk, dislodgement and patient discomfort.
The company’s lead product candidate, the Freedom PICC System, consists of a low‐profile, subcutaneous port connected to a flexible catheter designed for peripheral insertion.
Featured Articles
- Five stocks we like better than enVVeno Medical
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
- MarketBeat Week in Review – 06/22 – 06/26
Receive News & Ratings for enVVeno Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enVVeno Medical and related companies with MarketBeat.com's FREE daily email newsletter.
